I booked a nice profit on SNGX today, as it spiked up on news of a patent. I’ll be looking to buy back into this company sometime likely within the next couple weeks. I also sold BLRX and will be likely buying that one back sometime in September. It was just a really slow mover and my money is served better in a more active stock.
I added to my position in CKPT, which closed up higher and finished near the high of the day. The chart looks primed for a continuation to my targets soon.
I am also still holding SELB, ADMA, VKTX and VSTM in the portfolio as well.
Reminder: Charts are updated every Sunday evening for the next week!
—– Related —–
FREE DOWNLOAD
Kyle Dennis FREE EBOOK “The $2.9 Million Biotech Trader Playbook”
This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.
Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.
This is normally $97.00, but it’s yours FREE!
Catalyst Swing Names (1-4 week holds) that I am watching
Checkpoint Therapeutics (CKPT)
Catalyst Dates: Phase 1/2 late breaking data due out September 24th
Buy Zone: $3.55 to $3.95
Profit Zone: $4.50 or higher
Stop Zone: $3.30 or below
BioLineRX (BLRX)
Catalyst Dates: Phase 2 topline results due out October 19th
Buy Zone: $.87 to $.92
Profit Zone: $1.00 or higher
Stop Zone: $.85 or below
Soligenix (SNGX)
Catalyst Dates: Phase 3 interim analysis due out in October 2018.
Buy Zone: $1.35 to $1.55
Profit Zone: $1.80 or higher
Stop Zone: $1.15 or below
Mirati Therapeutics (MRTX)
Catalyst Dates: Phase 1 and Phase 2 data due out October 21 and 22.
Buy Zone: $55.00 to $58.00
Profit Zone: $65.00 or higher
Stop Zone: $50.50 or below
Adma Biologics (ADMA)
Catalyst Dates: FDA Approval date of October 25th 2018.
Buy Zone: $5.50 to $5.80
Profit Zone: $6.25 or higher
Stop Zone: $5.30 or below
AcelRx (ACRX)
Catalyst Dates: FDA Approval date of November 3, likely to have an
Advisory Committee meeting announce beforehand.
Buy Zone: $2.60 to $2.90
Profit Zone: $3.40 or higher
Stop Zone: $2.50 or below
Verastem (VSTM)
Catalyst Dates: FDA approval date of October 5th. Earnings should be August 8th.
Buy Zone: $7.75 to $8.15
Profit Zone: $9.00 or higher
Stop Zone: $7.00 or below
Viking Therapeutics (VKTX)
Catalyst Dates: Phase 2 data due September 30th. Another Phase 2 data set due out likely in late 2018.
Buy Zone: $9.75 to $10.35
Profit Zone: $12.00 or higher
Stop Zone: $9.40 or below
Selecta Biosciences (SELB)
Catalyst Dates: Phase 2 data due out in October
Buy Zone: $12.00 to $13.00
Profit Zone: $16.00 or higher
Stop Zone: $11.50 or below
Trevena (TRVN)
Catalyst Dates: FDA Approval date of November 2, likely to have an
Advisory Committee meeting announce beforehand
Buy Zone: $1.40 to $1.60
Profit Zone: $2.10 or higher
Stop Zone: $1.30 or below
[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.